GlassScriptPhysician profile
Babak Hassid
NPI 1164740684
$51,227.52
in general payments reported to CMS, 2019-2025
21 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $6,144 · 2021: $6,120 · 2022: $3,690 · 2023: $5,022 · 2024: $503 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,634 · Travel and Lodging: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,634.21 |
| Travel and Lodging | $407.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $12,000.00 | 2019 | |
| Medtronic Vascular, INC. | $9,031.31 | 2019-2020 | |
| Cardiovascular Systems INC. | $7,496.98 | 2019-2023 | Diamondback Coronary |
| Medtronic, INC. | $7,008.99 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $6,160.75 | 2019-2024 | Avvigo Guidance System |
| Siemens Medical Solutions USA, INC. | $4,555.93 | 2019-2025 | Naeotom Alpha, Artis Icono Floor, Artis Icono Biplane |
| Abiomed | $1,341.54 | 2019-2021 | |
| Philips North America LLC | $1,034.59 | 2019-2022 | |
| Shockwave Medical, INC | $751.02 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $605.75 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $230.65 | 2020 | |
| Penumbra, INC. | $229.65 | 2020-2021 | |
| Amgen INC. | $149.99 | 2025 | Repatha |
| Bolton Medical INC | $149.11 | 2020 | |
| Terumo Medical Corporation | $125.00 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $123.74 | 2019 | |
| Teleflex LLC | $99.31 | 2022 | |
| Heartflow, INC. | $96.33 | 2020-2025 | |
| Pfizer INC. | $23.55 | 2024 | |
| Alnylam Pharmaceuticals INC. | $13.33 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Hassid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.